Herbert Smith Freehills advises on record $A555 million commercial office sale

Herbert Smith Freehills has advised QIC on the sale of one of its flagship commercial office buildings in Sydney for A$555 million.

In what is widely tipped to be the largest Australian commercial office deal of the year, the sale attracted extraordinary interest both nationally and internationally, with more than 40 qualified bidders being granted access to the Herbert Smith Freehills Data Room. The sale is said to reflect a purchasing cap rate of 5.5%, the first such sale in Australia below 6% for many years.

More >>

Tags:  Herbert Smith Freehills LLP

Simpson Thacher Represents the Initial Purchasers in Micron Technology, Inc.’s $1.15 Billion Senior Notes Offering

The Firm recently represented the initial purchasers, led by Morgan Stanley, Goldman, Sachs & Co., and Credit Suisse, in connection with Micron Technology, Inc.’s offering of $1.15 billion aggregate principal amount of 5.50% Senior Notes due 2025. The notes were offered in reliance on Rule 144A and Regulation S under the Securities Act of 1933, as amended.
More >>

Tags:  Simpson Thacher & Bartlett LLP

Orrick Advises Underwriters in Secondary Public Offering of Benefitfocus Common Stock

Orrick, Herrington & Sutcliffe LLP represented Goldman, Sachs & Co., Deutsche Bank Securities Inc. and Jefferies LLC as joint book-running managers and representatives of the underwriters for a secondary public offering by selling stockholders of 2,854,560 shares of Benefitfocus, Inc. common stock.  The gross proceeds raised in the offering by the selling stockholders were approximately $110 million.  The selling stockholders were funds affiliated with Goldman Sachs that have been stockholders of the company since 2007.

More >>

Tags:  Orrick, Herrington & Sutcliffe LLP

Magellan Health, Inc. $250 Million Revolving and $250 Million Term Loan Facilities

Davis Polk advised Citibank, N.A., as administrative agent in connection with a $250 million revolving credit facility and a $250 million delayed draw term loan facility for Magellan RX Management, Inc., a direct subsidiary of Magellan Health, Inc. The proceeds of the loans will be used from time to time for general corporate purposes.

More >>

The Dun & Bradstreet Corporation $1 Billion Revolving Credit and Competitive Advance Facility

Davis Polk advised J.P. Morgan Securities LLC as sole lead arranger and bookrunner and JPMorgan Chase Bank, N.A. as administrative agent in connection with a $1 billion senior unsecured revolving credit and competitive advance facility provided to The Dun & Bradstreet Corporation, which amends and restates the company’s existing $800 million facility. Dun & Bradstreet will use the proceeds of the amended and restated credit facility for general corporate purposes.

More >>